EP Patent

EP4154900B1 — Therapeutic agents for reducing parathyroid hormone levels

Assigned to Kai Pharmaceuticals Inc · Expires 2024-08-28 · 2y expired

What this patent protects

Patent listed against Parsabiv.

Drugs covered by this patent

Patent Metadata

Patent number
EP4154900B1
Jurisdiction
EP
Classification
—
Expires
2024-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Kai Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.